![]() |
Volumn 52, Issue 2, 1996, Pages 225-230
|
Cidofovir
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
CIDOFOVIR;
DNA POLYMERASE;
ENZYME INHIBITOR;
PROBENECID;
SODIUM CHLORIDE;
VIRUS ENZYME;
ACIDOSIS;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ANIMAL EXPERIMENT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG TOLERABILITY;
ENZYME INHIBITION;
FEVER;
HUMAN;
HUMAN CYTOMEGALOVIRUS;
INTRAVENOUS DRUG ADMINISTRATION;
MAINTENANCE THERAPY;
MAJOR CLINICAL STUDY;
META ANALYSIS;
NEPHROTOXICITY;
NEUTROPENIA;
NONHUMAN;
PROTEIN PHOSPHORYLATION;
RETINITIS;
REVIEW;
VIRUS INFECTION;
VIRUS RESISTANCE;
|
EID: 0029741644
PISSN: 00126667
EISSN: None
Source Type: Journal
DOI: 10.2165/00003495-199652020-00006 Document Type: Review |
Times cited : (140)
|
References (0)
|